ATRenew Inc. Sponsored ADR RERE
3.94
0.01
0.25%
as of 25 Sep
- Market cap
- $517.7M
- P/E
- 13.6×
Follow RERE
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
13.34 | 18.76 | 26.50 | 28.75 |
+8 more quarters Free account |
P/S ratio |
0.26 | 0.35 | 0.43 | 0.41 | |
P/FCF ratio |
6.53 | 7.90 | 8.95 | 21.66 | |
P/Operating CF |
(15.78) | (19.08) | (21.62) | 12.64 | |
P/B ratio |
1.64 | 1.98 | 2.25 | 2.20 | |
Price to Tangible BV |
1.64 | 1.99 | 2.25 | 2.21 | |
EV/Sales |
0.21 | 0.30 | 0.36 | 0.31 | |
EV/EBITDA |
7.76 | 12.10 | 16.43 | 17.69 | |
EV/Operating CF |
3.89 | 5.20 | 5.61 | 9.17 | |
EV/FCF |
5.19 | 6.94 | 7.49 | 16.15 | |
Quick Ratio |
1.23 | 1.19 | 1.44 | 2.09 | |
Current Ratio |
2.36 | 2.42 | 2.49 | 3.30 | |
Net Debt/EBITDA |
(7.42) | (5.21) | (8.30) | (16.82) | |
Debt/Assets |
7.23% | 4.92% | 5.41% | 2.83% | |
Debt/Equity |
0.11 | 0.07 | 0.08 | 0.04 | |
Asset Turnover |
4.28 | 4.06 | 3.88 | 3.71 | |
Operating CF/Net income |
0.00 | 0.00 | (3.07) | 0.00 | |
Capex/Depreciation |
— | — | (1.19) | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.13% | 9.31% | 8.46% | 8.51% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.80% | 0.00% | |
Graham Net Nets |
0.45 | 0.35 | 0.31 | 0.38 | |
Graham Number |
0.00 | 0.00 | 3.26 | 0.00 | |
Earnings Yield |
7.49% | 5.33% | 3.77% | 3.48% | |
Free Cash Flow Yield |
15.31% | 12.65% | 11.17% | 4.62% | |
Revenue per Share |
4.03 | 3.70 | 3.92 | 2.99 | |
Operating CF per Share |
0.00 | 0.00 | (0.25) | 0.00 | |
Capex per Share |
0.00 | 0.00 | (0.08) | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | (0.33) | 0.00 | |
Cash per Share |
1.08 | 0.76 | 1.07 | 1.27 | |
Shareholders Equity per Share |
2.48 | 2.37 | 2.36 | 2.26 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.48 | 2.37 | 2.36 | 2.26 | |
Free Cash Flow |
— | — | (79.09) | — | |
Working Capital |
432.27 | 405.90 | 405.85 | 428.99 | |
Capital Expenditures |
— | — | (19.81) | — | |
Net Current Asset Value |
420.36 | 396.17 | 395.50 | 417.83 | |
EV/EBIT |
7.76 | 12.10 | 16.43 | 17.69 | |
Capex to Sales |
0.00 | 0.00 | 0.02 | 0.00 | |
Net Profit Margin |
1.95% | 2.19% | 2.04% | 1.76% | |
Price to Operating Income |
9.78 | 13.78 | 19.65 | 23.73 | |
| Other line items | |||||
Average Receivables |
115.24 | 116.38 | 90.32 | 74.94 | |
Average Payables |
25.10 | 26.82 | 35.73 | 17.78 | |
Average Inventory |
164.95 | 158.45 | 113.45 | 97.39 | |
Average Assets |
827.52 | 802.85 | 775.27 | 726.13 | |
Average Common Equity |
— | — | 563.81 | — |
Columns are period end dates